Compare INMB & VIDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INMB | VIDA |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.9M | 64.7M |
| IPO Year | 2018 | 2026 |
| Metric | INMB | VIDA |
|---|---|---|
| Price | $2.39 | $2.59 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.40 | N/A |
| AVG Volume (30 Days) | ★ 342.0K | 57.7K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.85 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $50,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 257.14 | N/A |
| 52 Week Low | $1.09 | $2.06 |
| 52 Week High | $2.48 | $4.25 |
| Indicator | INMB | VIDA |
|---|---|---|
| Relative Strength Index (RSI) | 71.42 | 42.34 |
| Support Level | $1.37 | $2.18 |
| Resistance Level | N/A | $2.85 |
| Average True Range (ATR) | 0.13 | 0.19 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 87.50 | 27.35 |
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.